Autotelic Bio sell "ATB-101"
Basic Information
793
55
7
3.9(21)
Category
Subcategory & Sub-subcategory
/
Trade Type
Sell
Product Name
ATB-101
Details
Manufacturer(s)
- -
Specifications
- Dosage Form: Tablet (fixed-dose combination)
- Indication: Investigational fixed-dose combination (ARB + SGLT-2 inhibitor) for the treatment of hypertension and type 2 diabetes, currently in Phase 3 clinical trials
- Regulatory Approval Status: Phase 3 clinical development stage; not yet approved for commercial marketing
Documents
No documents
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment